CVE:COT Cotinga Pharmaceuticals Inc. (COT.V) (COT) Stock Price, News & Analysis → Could Your Accounts Be Frozen? (From Allegiance Gold) (Ad) Free COT Stock Alerts C$0.04 -0.03 (-41.67%) (As of 10/14/2020) Add Compare Share Share Today's RangeC$0.04▼C$0.0450-Day RangeC$0.04▼C$0.0452-Week RangeC$0.02▼C$0.12Volume1,000 shsAverage Volume20,281 shsMarket CapitalizationC$769,510.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cotinga Pharmaceuticals Inc. (COT.V) alerts: Email Address Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About Cotinga Pharmaceuticals Inc. (COT.V)Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.Read More COT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart COT Stock News HeadlinesMay 1, 2024 | wsj.comKalVista Pharmaceuticals Inc.February 14, 2024 | wsj.comLexicon Pharmaceuticals Inc.May 5, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. November 5, 2023 | morningstar.comAcumen Pharmaceuticals Inc ABOSJuly 22, 2023 | seekingalpha.comSXTP 60 Degrees Pharmaceuticals, Inc.April 28, 2023 | marketwatch.com8-K: ENANTA PHARMACEUTICALS INCFebruary 18, 2023 | seekingalpha.comIronwood Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call PresentationJanuary 24, 2023 | seekingalpha.comPTPI Petros Pharmaceuticals, Inc.May 5, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. October 11, 2022 | wsj.comAmylyx Pharmaceuticals Inc.August 12, 2022 | yahoo.comPepGen Reports Second Quarter 2022 Financial Results and Recent Corporate DevelopmentsMay 26, 2022 | finance.yahoo.comExagen Inc. to Participate in the William Blair 42nd Annual Growth Stock ConferenceSee More Headlines Receive COT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cotinga Pharmaceuticals Inc. (COT.V) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:COT CUSIPN/A CIKN/A Webcotingapharma.com Phone+1-519-8585157FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.05 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.00 per share Price / Cash Flow17.50 Book ValueC($0.18) per share Price / Book-0.20Miscellaneous Outstanding Shares21,986,000Free FloatN/AMarket CapC$769,510.00 OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMs. Alison D. SilvaCEO, Pres & DirectorDr. Richard T. Ho (Age 58)Chief Scientific Officer Comp: $323.16kMr. Victor Hugo C.M.A. (Age 51)C.P.A., Chief Financial Officer Mr. Paul PapiVP of Investor RelationsKey CompetitorsiCo TherapeuticsCVE:ICOPascal BiosciencesCVE:PASBioasis TechnologiesCVE:BTISolarvest BioEnergyCVE:SVSMedifocus Inc. (MFS.V)CVE:MFSView All Competitors COT Stock Analysis - Frequently Asked Questions How have COT shares performed in 2024? Cotinga Pharmaceuticals Inc. (COT.V)'s stock was trading at C$0.04 at the beginning of the year. Since then, COT stock has increased by 0.0% and is now trading at C$0.04. View the best growth stocks for 2024 here. Is Cotinga Pharmaceuticals Inc. (COT.V) a good dividend stock? Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) pays an annual dividend of C$0.24 per share and currently has a dividend yield of 0.00%. What other stocks do shareholders of Cotinga Pharmaceuticals Inc. (COT.V) own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cotinga Pharmaceuticals Inc. (COT.V) investors own include Cascades (CAS), Aurora Cannabis (ACB), Advantage Lithium Corp. (AAL.V) (AAL), InPlay Oil (IPO), Harvest One Cannabis (HVT), Exchange Income (EIF), Datametrex AI (DM), Canadian National Railway (CNI) and Alimentation Couche-Tard (ATD.B). How do I buy shares of Cotinga Pharmaceuticals Inc. (COT.V)? Shares of COT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:COT) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsCharles Payne Demystifies OptionsUnstoppable ProsperityAutomatic Income (from home)Awesomely, LLCThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cotinga Pharmaceuticals Inc. (COT.V) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.